Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 9
2004 6
2005 5
2006 9
2007 5
2008 5
2009 6
2010 5
2011 9
2012 6
2013 13
2014 7
2015 7
2016 9
2017 2
2018 2
2019 2
2020 3
2021 3
2022 17
2023 11
2024 1
2025 3
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
[Antipsychotics].
Yamada H, Hashimoto R. Yamada H, et al. Brain Nerve. 2023 May;75(5):579-584. doi: 10.11477/mf.1416202382. Brain Nerve. 2023. PMID: 37194535 Japanese.
Assessment and Treatment of Eating Disorders.
Yoshiuchi K, Yamada H, Takakura S, Isobe M, Maruyama K, Nagata T. Yoshiuchi K, et al. Among authors: yamada h. J Nutr Sci Vitaminol (Tokyo). 2022;68(Supplement):S46-S48. doi: 10.3177/jnsv.68.S46. J Nutr Sci Vitaminol (Tokyo). 2022. PMID: 36437014 Free article.
Management of unspecified anxiety disorder: Expert consensus.
Sakurai H, Inada K, Aoki Y, Takeshima M, Ie K, Kise M, Yoshida E, Tsuboi T, Yamada H, Hori H, Inada Y, Shimizu E, Mishima K, Watanabe K, Takaesu Y. Sakurai H, et al. Among authors: yamada h. Neuropsychopharmacol Rep. 2023 Jun;43(2):188-194. doi: 10.1002/npr2.12323. Epub 2023 Feb 21. Neuropsychopharmacol Rep. 2023. PMID: 36811273 Free PMC article.
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study.
Ochi S, Kodaka F, Hasegawa N, Tsuboi T, Ohi K, Igarashi S, Fukumoto K, Iga JI, Muraoka H, Iida H, Tagata H, Kashiwagi H, Numata S, Yamagata H, Takeshima M, Ichihashi K, Hashimoto N, Nagasawa T, Nakamura T, Matsumoto J, Yamada H, Hori H, Ueno SI, Inada K, Hashimoto R, Yasui-Furukori N. Ochi S, et al. Among authors: yamada h. Int J Neuropsychopharmacol. 2025 Apr 11;28(4):pyaf011. doi: 10.1093/ijnp/pyaf011. Int J Neuropsychopharmacol. 2025. PMID: 40153592 Free PMC article.
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical setting.
Igarashi S, Tsuboi T, Hasegawa N, Ochi S, Ohi K, Fukumoto K, Iga JI, Muraoka H, Iida H, Kodaka F, Numata S, Ichihashi K, Kashiwagi H, Nakamura T, Yamagata H, Takeshima M, Nagasawa T, Matsumoto J, Yamada H, Hori H, Inada K, Yasui-Furukori N, Hashimoto R, Watanabe K. Igarashi S, et al. Among authors: yamada h. BMC Psychiatry. 2025 Oct 9;25(1):957. doi: 10.1186/s12888-025-07445-4. BMC Psychiatry. 2025. PMID: 41068670 Free PMC article.
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.
Okada T, Hori H, Hasegawa N, Murata A, Kyou Y, Kodaka F, Iida H, Ochi S, Takaesu Y, Tsuboi T, Iga JI, Ichihashi K, Muraoka H, Furihata R, Yasui-Furukori N, Usami M, Onitsuka T, Ogasawara K, Tagata H, Takeshima M, Ohi K, Numata S, Hashimoto N, Yamada H, Makinodan M, Komatsu H, Hishimoto A, Yamagata H, Kido M, Kubota C, Atake K, Yamada H, Nagasawa T, Matsumoto J, Miura K, Inada K, Watanabe K, Suda S, Hashimoto R. Okada T, et al. Among authors: yamada h. J Clin Psychopharmacol. 2022 Nov-Dec 01;42(6):591-593. doi: 10.1097/JCP.0000000000001604. Epub 2022 Oct 3. J Clin Psychopharmacol. 2022. PMID: 36193896 No abstract available.
Clinical practice for unspecified anxiety disorder in primary care.
Sakurai H, Takeshima M, Inada K, Aoki Y, Ie K, Kise M, Yoshida E, Tsuboi T, Yamada H, Hori H, Inada Y, Shimizu E, Mishima K, Watanabe K, Takaesu Y. Sakurai H, et al. Among authors: yamada h. PCN Rep. 2023 Jun 28;2(3):e118. doi: 10.1002/pcn5.118. eCollection 2023 Sep. PCN Rep. 2023. PMID: 38867823 Free PMC article.
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.
Ogasawara K, Numata S, Hasegawa N, Nakataki M, Makinodan M, Ohi K, Takeshima M, Tsuboi T, Hashimoto N, Onitsuka T, Muraoka H, Hori H, Ichihashi K, Inagaki T, Yasui-Furukori N, Hishimoto A, Sugiyama N, Fukumoto K, Nagasawa T, Matsumoto J, Takaesu Y, Furihata R, Nemoto K, Nakamura T, Usami M, Miura K, Fujimoto M, Tagata H, Yamada H, Komatsu H, Ochi S, Atake K, Katsumoto E, Kido M, Kishimoto T, Suwa T, Yamamura S, Iga JI, Iida H, Inada K, Watanabe K, Hashimoto R. Ogasawara K, et al. Among authors: yamada h. Neuropsychopharmacol Rep. 2022 Jun;42(2):221-225. doi: 10.1002/npr2.12245. Epub 2022 Mar 10. Neuropsychopharmacol Rep. 2022. PMID: 35272393 Free PMC article.
140 results